Skip to main content

A Phase III Randomized, Double-Blind Trial to Evaluate the Efficacy of Uproleselan Administered with Chemotherapy versus Chemotherapy Alone in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

GlycoMimetics, Inc

Start Date

November 15, 2018

End Date

November 29, 2024
 

Administered By

Duke Cancer Institute

Awarded By

GlycoMimetics, Inc

Start Date

November 15, 2018

End Date

November 29, 2024